Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms

JAK2 V617F is the predominant driver mutation in patients with Philadelphia-negative myeloproliferative neoplasms (MPN). JAK2 mutations are also frequent in clonal hematopoiesis of indeterminate potential (CHIP) in otherwise “healthy” individuals. However, the period between mutation acquisition and...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuckey, Ruth, Bilbao-Sieyro, Cristina, Segura-Díaz, Adrián, Gómez-Casares, María Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454334/
https://www.ncbi.nlm.nih.gov/pubmed/37628880
http://dx.doi.org/10.3390/ijms241612700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454334/
https://www.ncbi.nlm.nih.gov/pubmed/37628880
http://dx.doi.org/10.3390/ijms241612700

Ejemplares similares